Search - Archive ouverte HAL Access content directly

Filter your results

43 Results
Structure: Internal structure identifier : 300122

Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study

Stephane Ducassou , Guy Leverger , Helder Fernandes , Hervé Chambost , Yves Bertrand et al.
British Journal of Haematology, 2017, 177 (5), pp.751-758. ⟨10.1111/bjh.14627⟩
Journal articles hal-02413031v1

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

M. Mohty , M. Labopin , M. L. Balère , G. Socié , N. Milpied et al.
Leukemia, 2010, 24 (11), pp.1867-74. ⟨10.1038/leu.2010.200⟩
Journal articles hal-00849647v1
Image document

Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Aline Clavert , Zinaida Peric , Eolia Brissot , Florent Malard , Thierry Guillaume et al.
Biology of Blood and Marrow Transplantation, 2016, 23 (1), pp.140-146. ⟨10.1016/j.bbmt.2016.10.011⟩
Journal articles inserm-01419231v1

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.

S. P. Robinson , C. Canals , J. J. Luang , H. Tilly , C. Crawley et al.
Bone Marrow Transplantation, 2013, 48, pp.1409-1414. ⟨10.1038/bmt.2013.83⟩
Journal articles hal-00849676v1

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Mauricette Michallet , Quoc-Hung Le , Mohamad Mohty , Thomas Prébet , Franck Nicolini et al.
Experimental Hematology, 2008, 36 (5), pp.535-44. ⟨10.1016/j.exphem.2008.01.017⟩
Journal articles istex inserm-00484237v1
Image document

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

Sébastien Heritier , Jean-François Emile , Mohamed-Aziz Barkaoui , Caroline Thomas , Sylvie Fraitag et al.
Journal of Clinical Oncology, 2016, 34 (25), pp.3023-3030. ⟨10.1200/JCO.2015.65.9508⟩
Journal articles inserm-02304878v1

Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and Survival

Anaïs Vallet , Bastien Oriano , Laurent Mortier , Stéphane Dalle , Caroline Dutriaux et al.
JAMA Dermatology, 2019, 155 (6), pp.673. ⟨10.1001/jamadermatol.2019.0425⟩
Journal articles hal-02863397v1

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

Sylvain Choquet , Veronique Leblond , Raoul Herbrecht , Gérard Socié , Anne-Marie Stoppa et al.
Blood, 2006, 107 (8), pp.3053-7. ⟨10.1182/blood-2005-01-0377⟩
Journal articles hal-00452946v1

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Marie Robin , Reza Tabrizi , Mohamad Mohty , Sabine Furst , Mauricette Michallet et al.
British Journal of Haematology, 2011, 152 (3), pp.331-9. ⟨10.1111/j.1365-2141.2010.08417.x⟩
Journal articles hal-00849650v1
Image document

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis

Eric Lippert , Olivier Mansier , Marina Migeon , Barbara Denys , Asa Nilsson et al.
Haematologica, 2014, 99, ⟨10.3324/haematol.2014.107656⟩
Journal articles inserm-01402419v1

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Philippe Moreau , Frédéric Garban , Michel Attal , Mauricette Michallet , Gérald Marit et al.
Blood, 2008, 112 (9), pp.3914-5. ⟨10.1182/blood-2008-07-168823⟩
Journal articles hal-00821148v1

Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.

Hélène Labussière Wallet , Mohamad Sobh , Stéphane Morisset , Marie Robin , Nathalie Fegueux et al.
Experimental Hematology, 2013, 41 (11), pp.924-933. ⟨10.1016/j.exphem.2013.05.297⟩
Journal articles hal-00849674v1
Image document

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

Gandhi Damaj , Alain Duhamel , Marie Robin , Yves Beguin , Mauricette Michallet et al.
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal articles inserm-00821506v1

Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial.

Gandhi Damaj , Rémy Gressin , Krimo Bouabdallah , Guillaume Cartron , Bachra Choufi et al.
Journal of Clinical Oncology, 2013, 31 (1), pp.104-10. ⟨10.1200/JCO.2012.43.7285⟩
Journal articles inserm-00868869v1

Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Claire Fabre , Serge Koscielny , Mohamad Mohty , Nathalie Fegueux , Didier Blaise et al.
Haematologica, 2012, 97 (4), pp.482-90. ⟨10.3324/haematol.2011.049742⟩
Journal articles hal-00849621v1

Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort

Nathalie Aladjidi , Helder Fernandes , Thierry Leblanc , Amélie Vareliette , Frédéric Rieux-Laucat et al.
Frontiers in Pediatrics, 2015, 3, ⟨10.3389/fped.2015.00079⟩
Journal articles hal-02413085v1
Image document

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams-075

Gaëlle Laboure , Marie-Cecile Parrens , Anjarasoa Tsaranazy , Magali Bordier , Steven Le Gouill et al.
55th Annual Meeting and Exposition of the American-Society-of-Hematology, Dec 2013, La Nouvelle Orléans, United States. 126 (23), pp.3920, 2015
Conference poster hal-01290432v1

Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia.

Romain Micol , Samer Kayal , Nizar Mahlaoui , Julien Beauté , Pauline Brosselin et al.
Journal of Allergy and Clinical Immunology, 2012, 129 (3), pp.770-7. ⟨10.1016/j.jaci.2011.09.047⟩
Journal articles hal-00796444v1

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

M. Chrétien , J. Corre , V. Lauwers-Cances , F. Magrangeas , Alice Cleynen et al.
Blood, 2015, 126 (25), pp.2713 - 2719. ⟨10.1182/blood-2015-06-650242⟩
Journal articles hal-01813432v1

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

Hervé Avet-Loiseau , Cyrille Hulin , Loic Campion , Philippe Rodon , Gerald Marit et al.
Journal of Clinical Oncology, 2013, 31 (22), pp.2806--2809. ⟨10.1200/JCO.2012.46.2598⟩
Journal articles hal-01064339v1

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Jean-Luc Harousseau , Herve Avet-Loiseau , Michel Attal , Catherine Charbonnel , Frederic Garban et al.
Journal of Clinical Oncology, 2009, 27 (34), pp.5720-6. ⟨10.1200/JCO.2008.21.1060⟩
Journal articles hal-00821143v1
Image document

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

Sébastien Héritier , Mohamed-Aziz Barkaoui , Jean Miron , Caroline Thomas , Despina Moshous et al.
British Journal of Haematology, 2018, 183 (4), pp.608-617. ⟨10.1111/bjh.15577⟩
Journal articles inserm-02299489v1
Image document

Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial

Nicolas Boissel , Aline Renneville , Thibaut Leguay , Pascale Cornillet Lefebvre , Christian Recher et al.
Haematologica, 2015, 100 (6), pp.780 - 785. ⟨10.3324/haematol.2014.114884⟩
Journal articles inserm-01820455v1

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

Benoit Tessoulin , P Ceballos , P. Chevallier , Didier Blaise , Olivier Tournilhac et al.
Bone Marrow Transplantation, 2016, 51 (9), pp.1184-1190. ⟨10.1038/bmt.2016.102⟩
Journal articles inserm-01419584v1
Image document

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag , Serge Koscielny , Jacques Bosq , Thibaut Leguay , Olivier Casasnovas et al.
The Lancet, 2016, 387 (10036), pp.2402 - 2411. ⟨10.1016/S0140-6736(15)01317-3⟩
Journal articles inserm-01419476v1
Image document

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients

Mathilde Lamarque , Céline Bossard , Adrien Contejean , Pauline Brice , Marie Parrens et al.
Haematologica, 2016, 101 (3), Epub 2015 Dec 24. ⟨10.3324/haematol.2015.135400⟩
Journal articles inserm-01419525v1
Image document

Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial

Didier Blaise , Raynier Devillier , Anne-Gaelle Lecoroller-Sorriano , Jean-Marie Boher , Agnès Boyer-Chammard et al.
Haematologica, 2015, 100 (2), pp.269-274. ⟨10.3324/haematol.2014.113571⟩
Journal articles hal-02167058v1

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

Patrice Chevallier , Richard M Szydlo , Didier Blaise , Reza Tabrizi , Mauricette Michallet et al.
Biology of Blood and Marrow Transplantation, 2012, 18 (2), pp.289-94. ⟨10.1016/j.bbmt.2011.07.013⟩
Journal articles hal-00849660v1

Disease status and stem cell source impact on the results of reduced intensity conditioning transplant for Hodgkin lymphoma: a retrospective study from the French Society of Bone Marrow Graft Transplantation and Cellular Therapy.

Ambroise Marcais , Raphael Porcher , Marie Robin , Mohamad Mohty , Mauricette Michalet et al.
Haematologica, 2013, epub ahead of print. ⟨10.3324/haematol.2012.080895⟩
Journal articles hal-00821128v1

Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp

Sebastian Costa , Michelle Byrne , Daniel Pissaloux , Veronique Haddad , Sandrine Paindavoine et al.
American Journal of Surgical Pathology, 2015, ⟨10.1097/PAS.0000000000000568⟩
Journal articles hal-01255859v1